Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up
The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Atrophic gastritis (AG) is a risk condition for gastric cancer and type I gastric carcinoids. Recent studies assessing the overall risk of gastric cancer and carcinoids in AG at long-term follow up are lacking. This study aimed to investigate in a prospective cohort of AG patients the occurrence of gastric cancer and carcinoids at long-term follow up. METHODS: A total of 200 AG patients from a prospective cohort (67% female, median age 55 years) with a follow up of 7.5 (range: 4-23.4) years were included. Inclusion criteria were presence of AG and at least one follow-up gastroscopy with biopsies at ≥4 years after AG diagnosis. Follow-up gastroscopies at 4-year intervals were performed. RESULTS: Overall, 22 gastric neoplastic lesions were detected (crude incidence 11%). Gastric cancer was diagnosed in four patients at a median follow up of 7.2 years (crude incidence 2%). Eleven type I gastric carcinoids were detected at a median follow up of 5.1 years (crude incidence of 5.5%). In seven patients, six low-grade and one high-grade dysplasia were found. The annual incidence rate person-year were 0.25% (95% confidence interval [CI]: 0.067-0.63%), 0.43% (95% CI: 0.17-0.89%), and 0.68% (95% CI: 0.34-1.21%) for gastric cancer, dysplasia, and type I-gastric carcinoids, respectively. The incidence rates of gastric cancer and carcinoids were not different (p = 0.07). CONCLUSION: This study shows an annual incidence rate of 1.36% person-year for gastric neoplastic lesions in AG patients at long-term follow up. AG patients are similarly exposed to gastric cancer and type I gastric carcinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the incidence rate of type I gastric NETs in patients with chronic AG is estimated as 0.4–0.7% per year,26,28”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [28]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465 · cited 1×
“pylori-positive patients and in those with severe gastric atrophy, corpus-predominant gastritis or intestinal metaplasia are at increased risk [10].”
BackgroundCorrea, P. (1992) · PubMed · Cited by 3,216
Pathology and Genetics of Tumours of the Digestive System
(2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01219.x · Cited by 1,314
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
Gastric cancer: global pattern of the disease and an overview of environmental risk factors
Forman, D., & Burley, V. J. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.04.008 · Cited by 457 · cited 1×
“East–West), in particular with regard to gastric cancer [45].”
BackgroundGastric mucosal atrophy: interobserver consistency using new criteria for classification and grading
Rugge, M., Correa, P., Dixon, M. F., Fiocca, R., Hattori, T., Lechago, J., Leandro, G., Price, A. B., Sipponen, P., Solcia, E., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01301.x · Cited by 372 · cited 1×
“Atrophic gastritis (AG) is characterized by the loss of gastric glands replaced by connective tissue or glandular structures inappropriate for location giving arise to nonmetaplastic or metaplastic atrophy and – as a consequence – to hypochlorhydria and hypergastrinemia [1].”
Background
Research works printed but not linked: 4
- Correa P, 1992, Cancer Res, 52, 6735
- Bordi C, 1998, Yale J Biol Med, 71, 273
- Bordi C, 1995, Am J Surg Pathol, 19, S8
- Waldum HL, 2013, Acta Physiol (Oxf)
Cited by
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
“36% person-year for any gastric neoplasia (including dysplasia and neuroendocrine tumors) [109, 114].”
BackgroundSelf-citationAGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
Lenti, M. V., Rugge, M., Lahner, E., Miceli, E., Toh, B.-H., Genta, R. M., De Block, C., Hershko, C., & Di Sabatino, A. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0187-8 · Cited by 350
Self-citationLahner, E., Zagari, R. M., Zullo, A., Di Sabatino, A., Meggio, A., Cesaro, P., Lenti, M. V., Annibale, B., & Corazza, G. R. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.09.016 · Cited by 187
Self-citationThe changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective
Massironi, S., Zilli, A., Elvevi, A., & Invernizzi, P. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.08.011 · Cited by 173
Metadata
- Authors
- Lahner, E., Esposito, G., Pilozzi, E., Purchiaroni, F., Corleto, V. D., Di Giulio, E., & Annibale, B.
- Affiliations
- Azienda Ospedaliera Sant'Andrea (IT)
- Corresponding author
- Annibale, Bruno
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2015-02-03
- Volume
- 50
- Issue
- 7
- Pages
- 856-865
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2116777095
- Cited by
- 97
- References
- 47
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 3 · 2022: 8 · 2021: 16 · 2020: 18 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 2 · 2015: 4
- FWCI
- 6.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Sapienza Università di Roma
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- atrophic gastritis, gastric cancer, stomach neoplasms, dysplasia, incidence, long-term follow-up, risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Biopsy, Carcinoid Tumor, Female, Gastritis, Atrophic, Gastroscopy, Humans, Male, Middle Aged, Neoplasm Staging, Regression Analysis, Risk Factors, Stomach Neoplasms, Cohort Studies, Multivariate Analysis, Helicobacter pylori, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. https://app.cochat.ai/papers/10.3109/00365521.2015.1010570
- The paper
- Lahner, E., Esposito, G., Pilozzi, E., Purchiaroni, F., Corleto, V. D., Di Giulio, E., & Annibale, B. (2015). Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365521.2015.1010570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.